DailyStocks Stock Article Search

https://seekingalpha.com/article/4719190-draftkings-this-betting-behemoth-is-on-sale-we-see-100-percent-upside?source=feed_tag_editors_picks Sep 05, 2024 - DraftKings is one of our favorite stocks on the market. The company's growth, margins, and expansion opportunities are all extremely robust. Read more here. 0

https://www.cnbc.com/2024/09/04/were-starting-a-position-in-another-stock-that-should-see-a-lift-from-fed-rate-cuts.html Sep 05, 2024 - We're starting the position on the smaller side, leaving room for us to take advantage of any September volatility that may occur. 0

https://www.zacks.com/stock/news/2331760/mplx-lp-mplx-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2331760 Sep 04, 2024 - MPLX LP (MPLX) concluded the recent trading session at $42.43, signifying a -0.49% move from its prior day's close. 0

https://www.zacks.com/stock/news/2331769/kb-home-kbh-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2331769 Sep 04, 2024 - In the most recent trading session, KB Home (KBH) closed at $80.02, indicating a -1.14% shift from the previous trading day. 0

https://www.zacks.com/stock/news/2331411/wall-street-analysts-see-a-28-42-upside-in-pra-group-praa-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2331411 Sep 04, 2024 - The mean of analysts' price targets for PRA Group (PRAA) points to a 28.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. 0

https://www.zacks.com/stock/news/2331412/wall-street-analysts-see-a-27-55-upside-in-tsmc-tsm-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2331412 Sep 04, 2024 - The consensus price target hints at a 27.6% upside potential for TSMC (TSM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://www.zacks.com/stock/news/2331414/wall-street-analysts-see-a-58-78-upside-in-enliven-therapeutics-inc-elvn-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2331414 Sep 04, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 58.8% in Enliven Therapeutics, Inc. (ELVN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2331417/wall-street-analysts-see-a-31-16-upside-in-groupon-grpn-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2331417 Sep 04, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 31.2% in Groupon (GRPN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.rttnews.com/story.aspx?Id=3472841 Sep 04, 2024 - Shares of Dollar Tree, Inc. were losing nearly 13 percent in the pre-market activity on the Nasdaq after the discount retail chain on Wednesday issued third-quarter outlook and trimmed fiscal 2024 forecast, both below market estimates. The outlook reflects its second-quarter results with weak earnings, also below the Street view, despite slight growth in net sales. 0

https://www.zacks.com/stock/news/2330826/wall-street-analysts-see-a-332-28-upside-in-adverum-biotechnologies-advm-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2330826 Sep 03, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 332.3% in Adverum Biotechnologies (ADVM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0